XML 74 R66.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended 260 Months Ended
Apr. 22, 2025
Apr. 03, 2025
Feb. 20, 2025
Jan. 24, 2025
Jan. 26, 2024
Jan. 24, 2025
Jan. 26, 2024
Jan. 24, 2025
Oct. 25, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Modification of liability-classified awards             $ 4    
Total stock-based compensation expense       $ 103 $ 89 $ 291 269    
Unrecognized compensation expense related to equity awards       672   $ 672   $ 672  
Unrecognized compensation expense will be amortized on a straight-line basis over a weighted-average remaining period, in years           2 years      
Stock repurchase program, authorized amount       $ 17,100   $ 17,100   $ 17,100 $ 1,000
Repurchase of common stock, shares               379,000,000  
Average price of common stock repurchased under repurchase program               $ 43.59  
Aggregate purchase price of common stock authorized under repurchase program           $ 900 $ 800 $ 16,500  
Cash dividends declared, per common share     $ 0.52 $ 0.52 $ 0.5 $ 1.56 $ 1.5    
Dividends [Member] | Subsequent Event                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Cash dividend payable date Apr. 23, 2025                
Cash dividend record date   Apr. 04, 2025              
Performance Based Restricted Stock Unit                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
RSUs granted, Number of Shares           3,000,000      
RSUs granted, Weighted-Average Grant Date Fair Value           $ 126.96      
Vesting period, description           For the remaining half of the PBRSUs granted in the nine months ended January 24, 2025, the number of shares used to calculate the settlement amount will depend upon the Company's billings result average over the three-year performance period. The billings result average is computed based on achievement against annual billings targets, with each target set at the beginning of the respective fiscal year, during the three-year performance period. Billings for purposes of measuring the performance of these PBRSUs means the total obtained by adding net revenues as reported on the Company's Consolidated Statements of Income to the amount reported as the change in deferred revenue and financed unearned services revenue on the Consolidated Statements of Cash Flows for the applicable measurement period, excluding the impact of fluctuations in foreign currency exchange rates.      
RSUs grant date fair value       $ 62   $ 62   $ 62  
Performance Based Restricted Stock Unit | PBRSU Three                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period           3 years      
Minimum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Percentage of Common stock issued to settle PBRSUs of target shares granted           0.00%      
Maximum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Percentage of Common stock issued to settle PBRSUs of target shares granted           200.00%